The role of UPR‐related long noncoding RNAs in development of endocrine resistance in breast cancer

Breast cancer patients who express estrogen receptor α (ER) typically receive endocrine therapy as a first‐line treatment. Most ER‐positive breast cancer patients initially respond to endocrine therapy, but up to 40% of patients develop resistance over time, and the main mechanism is aberrant activa...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of cancer Ročník 157; číslo 12; s. 2434 - 2446
Hlavní autoři:	Liu, Wen, Gupta, Sahil, Gupta, Sanjeev
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Hoboken, USA John Wiley & Sons, Inc 15.12.2025 Wiley Subscription Services, Inc
Témata:	Animals Antineoplastic Agents, Hormonal - pharmacology Antineoplastic Agents, Hormonal - therapeutic use Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - genetics Breast Neoplasms - pathology Cell fate Drug Resistance, Neoplasm - genetics endocrine resistance Endocrine therapy Endoplasmic reticulum Endoplasmic Reticulum Stress - genetics Estrogen receptors Female Gene Expression Regulation, Neoplastic Humans long noncoding RNA Microenvironments Non-coding RNA Patients Protein folding RNA, Long Noncoding - genetics Signal Transduction unfolded protein response Unfolded Protein Response - genetics long noncoding RNA unfolded protein response breast cancer endocrine resistance
ISSN:	0020-7136, 1097-0215, 1097-0215
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!